AAOI Applied Optoelectronics | Target Lowered by | B. Riley Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.22 -3.0% | $16.00 ➝ $12.00 | Neutral | |
AAOI Applied Optoelectronics | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Kang Subscribe to MarketBeat All Access for the recommendation accuracy rating | $10.22 -3.0% | $16.00 ➝ $12.00 | Neutral ➝ Neutral | |
AAOI Applied Optoelectronics | Target Lowered by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.22 -3.0% | $20.00 ➝ $16.00 | Buy ➝ Buy | |
ACAD ACADIA Pharmaceuticals | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.25 +0.3% | $26.00 ➝ $22.00 | Neutral ➝ Neutral | |
ACRE Ares Commercial Real Estate | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.90 +1.6% | $7.50 ➝ $7.00 | Market Perform ➝ Market Perform | |
ADC Agree Realty | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.14 +1.1% | $60.00 ➝ $62.00 | Neutral ➝ Neutral | |
|
ADMA ADMA Biologics | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.81 +27.1% | $7.50 ➝ $10.00 | Buy ➝ Buy | |
ADMA ADMA Biologics | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.81 +27.1% | $10.00 ➝ $12.00 | Buy ➝ Buy | |
ADMA ADMA Biologics | Target Raised by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.81 +27.1% | $8.00 ➝ $10.00 | Overweight ➝ Overweight | |
ADMA ADMA Biologics | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.81 +27.1% | $8.00 ➝ $10.00 | Strong-Buy ➝ Strong-Buy | |
ADNT Adient | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.91 +0.0% | $35.00 ➝ $32.00 | Underweight ➝ Underweight | |
ADVM Adverum Biotechnologies | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating | $9.30 -3.2% | $30.00 | Buy ➝ Buy | |
AFL Aflac | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $86.10 +0.8% | $81.00 ➝ $82.00 | Equal Weight ➝ Equal Weight | |
AFRM Affirm | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.59 -9.3% | $48.00 ➝ $46.00 | Market Perform ➝ Market Perform | |
AIG American International Group | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.11 +0.3% | $80.00 ➝ $82.00 | Equal Weight ➝ Equal Weight | |
AKAM Akamai Technologies | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $150.00 ➝ $135.00 | Positive ➝ Positive | |
AKAM Akamai Technologies | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $145.00 ➝ $125.00 | Buy ➝ Buy | |
AKAM Akamai Technologies | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $135.00 ➝ $120.00 | Outperform ➝ Outperform | |
AKAM Akamai Technologies | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $138.00 ➝ $119.00 | Overweight ➝ Overweight | |
AKAM Akamai Technologies | Target Lowered by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $138.00 ➝ $115.00 | Outperform ➝ Outperform | |
AKAM Akamai Technologies | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $117.00 ➝ $106.00 | Equal Weight ➝ Equal Weight | |
AKAM Akamai Technologies | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $115.00 ➝ $92.00 | Sector Perform ➝ Sector Perform | |
AKAM Akamai Technologies | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $136.00 ➝ $114.00 | Overweight ➝ Overweight | |
AKAM Akamai Technologies | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $120.00 ➝ $110.00 | Hold ➝ Hold | |
AKAM Akamai Technologies | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.19 -11.0% | $130.00 ➝ $129.00 | Buy ➝ Buy | |
ALGM Allegro MicroSystems | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.76 -3.3% | $35.00 ➝ $32.00 | Overweight ➝ Overweight | |
ALGM Allegro MicroSystems | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.76 -3.3% | $45.00 ➝ $35.00 | Buy ➝ Buy | |
ALGM Allegro MicroSystems | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.76 -3.3% | $35.00 ➝ $32.00 | Buy ➝ Buy | |
ALGM Allegro MicroSystems | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.76 -3.3% | $40.00 ➝ $33.00 | Buy ➝ Buy | |
ALIT Alight | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.68 -0.3% | $14.00 ➝ $12.00 | Outperform ➝ Outperform | |
ALL Allstate | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $172.72 +0.7% | $146.00 ➝ $153.00 | Underweight ➝ Underweight | |
ALT Altimmune | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.22 -6.5% | $25.00 ➝ $24.00 | Market Outperform ➝ Market Outperform | |
AMLX Amylyx Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.76 -7.4% | $8.00 | Buy ➝ Buy | |
AMN AMN Healthcare Services | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.72 -10.1% | $75.00 | Market Outperform ➝ Market Outperform | |
AMPL Amplitude | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.12 -1.5% | $10.00 ➝ $9.00 | Underweight ➝ Underweight | |
AMPL Amplitude | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.12 -1.5% | $13.00 ➝ $11.00 | Neutral ➝ Neutral | |
AMPX Amprius Technologies | Target Lowered by | Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.97 -11.7% | $10.00 ➝ $9.00 | Buy ➝ Buy | |
AMTX Aemetis | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.00 -2.9% | $28.00 | Buy ➝ Buy | |
ANAB AnaptysBio | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Nierengarten Subscribe to MarketBeat All Access for the recommendation accuracy rating | $23.41 -10.8% | $34.00 | Outperform ➝ Outperform | |
APGE Apogee Therapeutics | Initiated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.22 +0.6% | $80.00 | Buy | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
APP AppLovin | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $86.43 +2.1% | $80.00 ➝ $98.00 | Buy ➝ Buy | |
AQST Aquestive Therapeutics | Initiated by | SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.09 -6.1% | $8.00 | Outperform | |
ARCT Arcturus Therapeutics | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.26 +1.8% | $87.00 ➝ $86.00 | Buy ➝ Buy | |
ARGX argenx | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $374.63 -2.1% | $451.00 ➝ $448.00 | Buy ➝ Buy | |
ARGX argenx | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $374.63 -2.1% | $471.00 ➝ $468.00 | Market Outperform ➝ Market Outperform | |
ARHS Arhaus | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.32 +5.3% | $19.00 ➝ $20.00 | Overweight ➝ Overweight | |
ARHS Arhaus | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.32 +5.3% | $16.00 ➝ $18.00 | Outperform ➝ Outperform | |
ARLO Arlo Technologies | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.43 -17.9% | $14.00 ➝ $17.00 | Buy ➝ Buy | |
ARLO Arlo Technologies | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.43 -17.9% | $13.75 ➝ $16.50 | Buy ➝ Buy | |
ARLO Arlo Technologies | Reiterated by | BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.43 -17.9% | $17.00 ➝ $17.00 | Buy ➝ Buy | |
ARWR Arrowhead Pharmaceuticals | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.08 -10.7% | $60.00 ➝ $60.00 | Buy ➝ Buy | |
ATO Atmos Energy | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.18 -2.1% | $121.00 ➝ $130.00 | Equal Weight ➝ Equal Weight | |
ATXS Astria Therapeutics | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.73 -4.3% | $22.00 | Outperform ➝ Outperform | |
ATXS Astria Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.73 -4.3% | $16.00 | Buy ➝ Buy | |
AVXL Anavex Life Sciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.81 -1.8% | $40.00 | Buy ➝ Buy | |
AXS AXIS Capital | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.53 +0.8% | $57.00 ➝ $63.00 | Underweight ➝ Underweight | |
AY Atlantica Sustainable Infrastructure | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.95 +3.1% | $20.00 ➝ $23.00 | Market Perform ➝ Market Perform | |
BAND Bandwidth | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.61 +0.4% | | Hold | |
BAX Baxter International | Downgraded by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.69 -0.7% | $40.00 | Buy ➝ Hold | |
BE Bloom Energy | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.15 -5.0% | $10.00 ➝ $13.00 | Hold ➝ Hold | |
BE Bloom Energy | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.15 -5.0% | $21.00 ➝ $20.00 | Outperform ➝ Outperform | |
BERY Berry Global Group | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.86 +0.2% | $74.00 ➝ $81.00 | Buy ➝ Buy | |
BHF Brighthouse Financial | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.68 -1.9% | $55.00 ➝ $50.00 | Neutral ➝ Neutral | |
BHF Brighthouse Financial | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.68 -1.9% | $51.00 ➝ $50.00 | Equal Weight ➝ Equal Weight | |
BIDU Baidu | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $108.66 -2.0% | $140.00 ➝ $130.00 | Buy ➝ Buy | |
BIGC BigCommerce | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.59 +0.8% | $14.00 | Buy ➝ Buy | |
BIGC BigCommerce | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.59 +0.8% | $7.00 ➝ $8.00 | Equal Weight ➝ Equal Weight | |
BILI Bilibili | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.07 +0.4% | $15.00 ➝ $17.00 | Buy ➝ Buy | |
BKH Black Hills | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.06 -0.9% | $56.00 ➝ $61.00 | Equal Weight ➝ Equal Weight | |
BLBD Blue Bird | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.74 +4.3% | $35.00 ➝ $43.00 | Overweight ➝ Overweight | |
BLND Blend Labs | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88 +3.6% | $2.65 ➝ $3.00 | Market Perform ➝ Market Perform | |
BLNK Blink Charging | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.82 -0.7% | $7.00 ➝ $5.00 | Buy ➝ Buy | |
BMBL Bumble | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.45
| $14.00 | Neutral ➝ Buy | |
BN Brookfield | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.22 -0.1% | $45.00 ➝ $46.00 | Market Perform ➝ Market Perform | |
BN Brookfield | Target Lowered by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.22 -0.1% | $50.00 ➝ $49.50 | Sector Outperform ➝ Sector Outperform | |
BRCC BRC | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.94 -11.6% | $6.00 ➝ $7.00 | Buy ➝ Buy | |
BRLT Brilliant Earth Group | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.69 +0.7% | $4.00 ➝ $4.00 | Outperform ➝ Outperform | |
BROS Dutch Bros | Upgraded by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.00 +9.8% | $33.00 ➝ $46.00 | Hold ➝ Buy | |
BTAI BioXcel Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.09 -9.5% | $10.00 | Buy ➝ Buy | |
BYND Beyond Meat | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.16 +1.7% | $9.00 ➝ $7.00 | Hold ➝ Hold | |
CAKE Cheesecake Factory | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.65 +4.4% | $38.00 ➝ $47.00 | Neutral ➝ Buy | |
CAMT Camtek | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.46 -1.3% | $92.00 ➝ $106.00 | Buy ➝ Buy | |
CAMT Camtek | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.46 -1.3% | $90.00 ➝ $105.00 | Overweight ➝ Overweight | |
CAMT Camtek | Reiterated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Ellis Subscribe to MarketBeat All Access for the recommendation accuracy rating | $90.46 -1.3% | $102.00 ➝ $110.00 | Buy ➝ Buy | |
CARG CarGurus | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.22 +8.7% | $26.00 ➝ $27.00 | Outperform ➝ Outperform | |
CARG CarGurus | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.22 +8.7% | $24.00 ➝ $25.00 | Buy ➝ Buy | |
CARG CarGurus | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.22 +8.7% | $27.00 ➝ $29.00 | Overweight ➝ Overweight | |
CARM Carisma Therapeutics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.48 -2.0% | $9.00 ➝ $8.00 | Buy ➝ Buy | |
CBSH Commerce Bancshares | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.68 -0.7% | $58.00 ➝ $60.00 | Market Perform ➝ Market Perform | |
CBUS Cibus | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.74 -0.6% | $25.00 | Buy ➝ Buy | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
CCAP Crescent Capital BDC | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.19 +1.4% | $18.00 ➝ $19.00 | Outperform ➝ Outperform | |
CCOI Cogent Communications | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.59 -3.4% | $88.00 ➝ $80.00 | Overweight ➝ Overweight | |
CCOI Cogent Communications | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.59 -3.4% | $84.00 ➝ $78.00 | Buy ➝ Buy | |
CCSI Consensus Cloud Solutions | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.11 +6.2% | $24.00 | Outperform ➝ Outperform | |
CE Celanese | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $156.65 -3.0% | $165.00 ➝ $180.00 | Outperform ➝ Outperform | |
CEVA CEVA | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61 -3.2% | $25.00 ➝ $20.00 | Neutral ➝ Neutral | |
CHRS Coherus BioSciences | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.90 -10.4% | $11.00 ➝ $12.00 | Buy ➝ Buy | |
CHUY Chuy's | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.10 -5.5% | $41.00 | Buy ➝ Buy | |
CHUY Chuy's | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.10 -5.5% | $40.00 | Overweight ➝ Overweight | |
CHUY Chuy's | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.10 -5.5% | $38.00 | Outperform ➝ Outperform | |
CLSK CleanSpark | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.57 -6.1% | $27.00 | Buy ➝ Buy | |
CMBM Cambium Networks | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.58 -11.2% | $9.75 ➝ $8.50 | Buy ➝ Buy | |
CMI Cummins | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $298.75 +1.4% | $272.00 ➝ $292.00 | Buy ➝ Buy | |
CMPO CompoSecure | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.69 -1.2% | $17.00 ➝ $18.00 | Buy ➝ Buy | |
CMRE Costamare | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.39 -0.3% | $11.00 ➝ $12.00 | Hold ➝ Hold | |
COLL Collegium Pharmaceutical | Downgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.50 -16.8% | $39.00 ➝ $39.00 | Overweight ➝ Neutral | |
COLL Collegium Pharmaceutical | Downgraded by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.50 -16.8% | | Buy ➝ Hold | |
CPK Chesapeake Utilities | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $111.72 +0.3% | $105.00 ➝ $115.00 | Equal Weight ➝ Equal Weight | |
CPRX Catalyst Pharmaceuticals | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.94 +1.9% | $24.00 ➝ $26.00 | Buy ➝ Buy | |
CRBG Corebridge Financial | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.55 -2.3% | $33.00 ➝ $34.00 | Overweight ➝ Overweight | |
CRL Charles River Laboratories International | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $227.92 -0.9% | $282.00 ➝ $270.00 | Outperform ➝ Outperform | |
CRNX Crinetics Pharmaceuticals | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.00 -2.9% | $80.00 | Market Outperform ➝ Market Outperform | |
CRNX Crinetics Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.00 -2.9% | $60.00 | Buy ➝ Buy | |
CRSP CRISPR Therapeutics | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.17 -4.4% | $102.00 ➝ $95.00 | Outperform ➝ Outperform | |
CVX Chevron | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.80 +0.2% | $156.00 ➝ $166.00 | Hold ➝ Hold | |
D Dominion Energy | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.07 +0.4% | $43.00 ➝ $54.00 | Underperform ➝ Neutral | |
DIOD Diodes | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.32 -9.4% | $67.00 ➝ $74.00 | Hold ➝ Hold | |
DIOD Diodes | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.32 -9.4% | $56.00 ➝ $72.00 | Neutral ➝ Neutral | |
DNA Ginkgo Bioworks | Downgraded by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.76 -17.4% | | Market Perform ➝ Underperform | |
DNTH Dianthus Therapeutics | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chico Subscribe to MarketBeat All Access for the recommendation accuracy rating | $24.29 -2.6% | $33.00 ➝ $38.00 | Outperform ➝ Outperform | |
DUOL Duolingo | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $188.12 -6.2% | $282.00 ➝ $265.00 | Overweight ➝ Overweight | |
ELUT Elutia | Target Lowered by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.28 +17.1% | $6.00 ➝ $5.00 | Overweight ➝ Overweight | |
EMBC Embecta | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.24 +0.6% | $16.00 ➝ $13.00 | Underweight ➝ Underweight | |
EMR Emerson Electric | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $115.55 0.0% | $105.00 ➝ $110.00 | Equal Weight ➝ Equal Weight | |
EMR Emerson Electric | Target Raised by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $115.55 0.0% | $130.00 ➝ $135.00 | Buy ➝ Buy | |
ENFN Enfusion | Initiated by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.05 -2.3% | $11.00 | Overweight | |
EPAM EPAM Systems | Downgraded by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $183.40 +0.8% | $300.00 ➝ $245.00 | Sector Outperform ➝ Sector Perform | |
EPAM EPAM Systems | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $183.40 +0.8% | $350.00 ➝ $210.00 | Buy ➝ Buy | |
EPAM EPAM Systems | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $183.40 +0.8% | $282.00 ➝ $203.00 | Hold ➝ Hold | |
EPC Edgewell Personal Care | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.96 +1.8% | $37.00 ➝ $40.00 | Equal Weight ➝ Equal Weight | |
EPRT Essential Properties Realty Trust | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.14 +0.1% | $26.00 ➝ $29.00 | Buy ➝ Buy | |
EQH Equitable | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.85 +0.5% | $46.00 ➝ $44.00 | Overweight ➝ Overweight | |
EQIX Equinix | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $757.68 -1.9% | $862.00 ➝ $859.00 | Buy ➝ Buy | |
ETNB 89bio | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.71 -4.4% | $31.00 ➝ $29.00 | Buy ➝ Buy | |
EVCM EverCommerce | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.09 +4.1% | $11.00 ➝ $12.00 | Outperform ➝ Outperform | |
EVCM EverCommerce | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.09 +4.1% | $12.00 ➝ $13.00 | Buy ➝ Buy | |
EVH Evolent Health | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.46 -9.3% | $44.00 ➝ $41.00 | Buy ➝ Buy | |
EVH Evolent Health | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.46 -9.3% | $38.00 ➝ $34.00 | Market Outperform ➝ Market Outperform | |
EVLV Evolv Technologies | Downgraded by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.36 -38.5% | $6.00 ➝ $3.50 | Buy ➝ Hold | |
EVLV Evolv Technologies | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.36 -38.5% | $7.00 ➝ $6.00 | Buy ➝ Buy | |
READ THIS – If You Missed Out On The AI Boom (Ad) Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy.
Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.” Click on Adam's shiny forehead for more details. |
EVRG Evergy | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.42 -0.5% | $57.00 ➝ $62.00 | Overweight ➝ Overweight | |
EXK Endeavour Silver | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.33
| $6.25 | Buy ➝ Buy | |
EYE National Vision | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.76 -2.6% | $19.00 ➝ $16.00 | Equal Weight ➝ Equal Weight | |
FATE Fate Therapeutics | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08 +4.6% | $11.00 ➝ $9.00 | Buy ➝ Buy | |
FATE Fate Therapeutics | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08 +4.6% | $7.00 ➝ $6.00 | Market Perform ➝ Market Perform | |
FATE Fate Therapeutics | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08 +4.6% | $7.00 ➝ $4.00 | Neutral ➝ Neutral | |
FIGS FIGS | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.39 -4.1% | $6.00 ➝ $6.00 | Market Perform ➝ Market Perform | |
FIGS FIGS | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.39 -4.1% | $7.50 ➝ $6.75 | Buy ➝ Buy | |
FLNC Fluence Energy | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.73 -10.8% | $31.00 ➝ $27.00 | Buy ➝ Buy | |
FLNC Fluence Energy | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.73 -10.8% | $32.00 ➝ $30.00 | Equal Weight ➝ Equal Weight | |
FLNC Fluence Energy | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.73 -10.8% | $20.00 ➝ $18.00 | Neutral ➝ Neutral | |
FLUX Flux Power | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.42 -25.3% | $10.00 ➝ $7.00 | Buy ➝ Buy | |
FLUX Flux Power | Target Lowered by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.42 -25.3% | $9.00 ➝ $6.00 | Buy ➝ Buy | |
FMC FMC | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.53 +0.8% | $65.00 ➝ $81.00 | Outperform ➝ Outperform | |
FNF Fidelity National Financial | Target Raised by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.53 -2.1% | $59.00 ➝ $60.00 | Overweight ➝ Overweight | |
FNKO Funko | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.21 +5.7% | $10.00 ➝ $11.00 | Buy ➝ Buy | |
FOLD Amicus Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.23 -2.6% | | Hold | |
FOLD Amicus Therapeutics | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.23 -2.6% | $14.00 ➝ $13.00 | Buy ➝ Buy | |
FOLD Amicus Therapeutics | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.23 -2.6% | $20.00 ➝ $19.00 | Buy ➝ Buy | |
FOLD Amicus Therapeutics | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.23 -2.6% | $20.00 ➝ $19.00 | Overweight ➝ Overweight | |
FOUR Shift4 Payments | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.08 +6.6% | $100.00 ➝ $75.00 | Overweight ➝ Overweight | |
FOUR Shift4 Payments | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.08 +6.6% | $99.00 | Buy ➝ Buy | |
FOUR Shift4 Payments | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.08 +6.6% | $70.00 ➝ $66.00 | Equal Weight ➝ Equal Weight | |
FROG JFrog | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.01 -18.7% | $52.00 ➝ $47.00 | Overweight ➝ Overweight | |
FROG JFrog | Target Lowered by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.01 -18.7% | $45.00 ➝ $40.00 | Sector Perform ➝ Sector Perform | |
FROG JFrog | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.01 -18.7% | $52.00 ➝ $46.00 | Overweight ➝ Overweight | |
FROG JFrog | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.01 -18.7% | $55.00 ➝ $45.00 | Buy ➝ Buy | |
FSK FS KKR Capital | Reiterated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.87 -0.1% | $20.00 ➝ $21.00 | Buy ➝ Buy | |
FSTR L.B. Foster | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.72 +4.5% | $23.00 ➝ $27.00 | Neutral ➝ Neutral | |
FTHM Fathom | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.42 -2.7% | $12.00 ➝ $8.00 | Buy ➝ Buy | |
FTHM Fathom | Target Lowered by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.42 -2.7% | $4.00 ➝ $2.50 | Overweight ➝ Overweight | |
FTHM Fathom | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.42 -2.7% | $4.50 ➝ $3.50 | Buy ➝ Buy | |
FUN Cedar Fair | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.60 +2.6% | $45.00 ➝ $50.00 | Buy ➝ Buy | |
FWRD Forward Air | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.44 -7.9% | $24.00 ➝ $14.00 | Neutral ➝ Neutral | |
G Genpact | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.20 +3.6% | $35.00 | Neutral ➝ Neutral | |
G Genpact | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.20 +3.6% | $39.00 ➝ $38.00 | Market Perform ➝ Market Perform | |
G Genpact | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.20 +3.6% | $40.00 | Buy ➝ Buy | |
GAIN Gladstone Investment | Reiterated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.22 +0.9% | $13.50 ➝ $14.00 | Neutral ➝ Neutral | |
GETY Getty Images | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.53 -9.0% | $8.00 ➝ $6.00 | Buy ➝ Buy | |
GHI Greystone Housing Impact Investors | Target Lowered by | Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.55 -0.2% | $20.00 ➝ $17.50 | Buy ➝ Buy | |
GHLD Guild | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.67 +1.6% | $17.00 | Outperform ➝ Outperform | |
GLOB Globant | Downgraded by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $173.04 -0.1% | $230.00 ➝ $200.00 | Sector Outperform ➝ Sector Perform | |
GLPI Gaming and Leisure Properties | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.27 +0.1% | $47.00 ➝ $46.00 | Neutral ➝ Neutral | |
GNK Genco Shipping & Trading | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.83 +0.5% | $27.00 ➝ $30.00 | Buy ➝ Buy | |
GO Grocery Outlet | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.89 -0.1% | $43.00 ➝ $25.00 | Buy ➝ Buy | |
GPCR Structure Therapeutics | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.82 -7.3% | $91.00 | Market Outperform ➝ Market Outperform | |
H Hyatt Hotels | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $152.20 0.0% | $153.00 ➝ $159.00 | Equal Weight ➝ Equal Weight | |
HAE Haemonetics | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.90 +3.6% | $115.00 ➝ $125.00 | Market Outperform ➝ Market Outperform | |
HAE Haemonetics | Target Raised by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.90 +3.6% | $105.00 ➝ $107.00 | Outperform ➝ Outperform | |
HAE Haemonetics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.90 +3.6% | | Hold | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
HAIN The Hain Celestial Group | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.03
| $8.00 ➝ $7.00 | Equal Weight ➝ Equal Weight | |
HBI Hanesbrands | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.96 +6.0% | $4.00 ➝ $5.00 | Equal Weight ➝ Equal Weight | |
HBT HBT Financial | Upgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.57 +2.2% | $23.00 | Market Perform ➝ Outperform | |
HCAT Health Catalyst | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.41 -3.9% | $14.00 ➝ $13.00 | Overweight ➝ Overweight | |
HD Home Depot | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Basham Subscribe to MarketBeat All Access for the recommendation accuracy rating | $346.44 -0.3% | $410.00 | Outperform ➝ Outperform | |
HG Hamilton Insurance Group | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.01 -0.7% | $16.00 ➝ $19.00 | Overweight ➝ Overweight | |
HIPO Hippo | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.98 -2.9% | $21.00 ➝ $22.00 | Outperform ➝ Outperform | |
HLVX HilleVax | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating | $13.84 -1.1% | $28.00 | Buy ➝ Buy | |
HMN Horace Mann Educators | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.11 -1.3% | $39.00 ➝ $37.00 | Neutral ➝ Neutral | |
HOOD Robinhood Markets | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.23 -6.2% | $18.00 ➝ $19.00 | Equal Weight ➝ Equal Weight | |
HRB H&R Block | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.53 +8.8% | $55.00 ➝ $55.00 | Outperform ➝ Outperform | |
HUBS HubSpot | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $598.25 +1.9% | $798.00 ➝ $767.00 | Buy ➝ Buy | |
HY Hyster-Yale Materials Handling | Reiterated by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.64 -1.7% | $80.00 ➝ $90.00 | Outperform ➝ Market Perform | |
IAC IAC | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.07 -0.5% | $80.00 ➝ $87.00 | Buy ➝ Buy | |
IAS Integral Ad Science | Target Lowered by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.53 +13.7% | $16.00 ➝ $13.00 | Outperform ➝ Outperform | |
IAS Integral Ad Science | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.53 +13.7% | $20.00 ➝ $18.00 | Buy ➝ Buy | |
IBP Installed Building Products | Target Raised by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $233.65 -1.3% | $250.00 ➝ $270.00 | Buy ➝ Buy | |
IBP Installed Building Products | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $233.65 -1.3% | $216.00 ➝ $220.00 | Sector Perform ➝ Sector Perform | |
IFF International Flavors & Fragrances | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.18 +0.1% | $87.00 ➝ $99.00 | Neutral ➝ Neutral | |
INDI indie Semiconductor | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.76 -0.5% | $10.00 ➝ $9.00 | Buy ➝ Buy | |
INDI indie Semiconductor | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.76 -0.5% | $10.00 ➝ $9.00 | Overweight ➝ Overweight | |
INDI indie Semiconductor | Reiterated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.76 -0.5% | $14.50 ➝ $13.50 | Buy ➝ Buy | |
INSM Insmed | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.97 -1.6% | $40.00 ➝ $43.00 | Overweight ➝ Overweight | |
INTA Intapp | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.74 +2.1% | $52.00 ➝ $46.00 | Overweight ➝ Overweight | |
IOVA Iovance Biotherapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.97 -18.4% | $32.00 | Buy ➝ Buy | |
IPI Intrepid Potash | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.65 +0.2% | $21.00 ➝ $23.00 | Market Perform ➝ Market Perform | |
IPSC Century Therapeutics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.13 +3.0% | $13.00 ➝ $11.00 | Buy ➝ Buy | |
IRON Disc Medicine | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.36 -1.3% | $70.00 | Buy ➝ Buy | |
IRON Disc Medicine | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.36 -1.3% | $40.00 ➝ $43.00 | Outperform ➝ Outperform | |
IRWD Ironwood Pharmaceuticals | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.00 +3.9% | $18.00 ➝ $14.00 | Buy ➝ Buy | |
ITGR Integer | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $113.95 -0.2% | $130.00 | Buy ➝ Buy | |
KGS Kodiak Gas Services | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.71 -1.9% | $28.00 ➝ $32.00 | Buy ➝ Buy | |
KLTR Kaltura | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.20 -3.2% | $5.00 ➝ $3.00 | Buy ➝ Buy | |
KNTK Kinetik | Target Raised by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.85 +2.3% | $38.00 ➝ $42.00 | Sector Outperform ➝ Sector Outperform | |
KZR Kezar Life Sciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.77 -4.9% | $20.00 | Buy ➝ Buy | |
LAW CS Disco | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.80 -15.7% | $15.00 ➝ $11.00 | Buy ➝ Buy | |
LCUT Lifetime Brands | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.61 +5.8% | $11.00 ➝ $12.00 | Buy ➝ Buy | |
LEA Lear | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $131.05 +1.4% | $150.00 ➝ $160.00 | Equal Weight ➝ Overweight | |
LEGH Legacy Housing | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.41 +10.7% | $25.00 | Outperform ➝ Outperform | |
LFMD LifeMD | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.32 +0.2% | $12.00 | Buy ➝ Buy | |
LILAK Liberty Latin America | Target Raised by | Pivotal Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.40 -3.3% | $17.00 ➝ $18.00 | Buy ➝ Buy | |
LNC Lincoln National | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.31 +0.2% | $28.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
LNW Light & Wonder | Downgraded by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.46 -0.1% | $111.00 ➝ $95.00 | Positive ➝ Neutral | |
LPTH LightPath Technologies | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.44 +8.3% | $3.00 | Buy ➝ Buy | |
MARA Marathon Digital | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.16 -12.7% | | Hold | |
MARA Marathon Digital | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.16 -12.7% | $19.00 ➝ $18.00 | Neutral ➝ Neutral | |
MARA Marathon Digital | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.16 -12.7% | $35.00 ➝ $27.00 | Buy ➝ Buy | |
MDGL Madrigal Pharmaceuticals | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Mamtani Subscribe to MarketBeat All Access for the recommendation accuracy rating | $205.25 -0.8% | $270.00 ➝ $200.00 | Neutral ➝ Neutral | |
MET MetLife | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.73 +0.3% | $86.00 ➝ $85.00 | Overweight ➝ Overweight | |
METC Ramaco Resources | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.95 -2.6% | $24.00 ➝ $20.00 | Buy ➝ Buy | |
METC Ramaco Resources | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.95 -2.6% | $24.00 ➝ $22.00 | Buy ➝ Buy | |
MGA Magna International | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.93 +1.1% | $65.00 ➝ $60.00 | Overweight ➝ Overweight | |
MGNX MacroGenics | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.31 -77.4% | $22.00 ➝ $16.00 | Market Outperform ➝ Market Outperform | |
MGNX MacroGenics | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.31 -77.4% | $25.00 ➝ $14.00 | Overweight ➝ Overweight | |
MGNX MacroGenics | Downgraded by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.31 -77.4% | | Buy ➝ Hold | |
MGNX MacroGenics | Downgraded by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.31 -77.4% | $29.00 ➝ $7.00 | Buy ➝ Hold | |
MGNX MacroGenics | Downgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.31 -77.4% | $24.00 ➝ $8.00 | Outperform ➝ Market Perform | |
MIRM Mirum Pharmaceuticals | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.76 -4.1% | $57.00 ➝ $53.00 | Overweight ➝ Overweight | |
MKSI MKS Instruments | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.50 +2.3% | $142.00 | Buy ➝ Buy | |
MKSI MKS Instruments | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.50 +2.3% | $125.00 ➝ $145.00 | Buy ➝ Buy | |
MMM 3M | Upgraded by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $98.96 +1.7% | $91.13 ➝ $115.00 | Hold ➝ Buy | |
MNMD Mind Medicine (MindMed) | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.26 +1.5% | $75.00 ➝ $35.00 | Buy ➝ Buy | |
MNPR Monopar Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.67 -5.6% | $2.00 | Buy ➝ Buy | |
MOGO Mogo | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.76 -1.7% | $8.00 | Buy ➝ Buy | |
MRC MRC Global | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.67 +7.1% | $15.00 ➝ $16.00 | Positive ➝ Positive | |
MTRN Materion | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $115.72 +2.4% | $156.00 ➝ $152.00 | Overweight ➝ Overweight | |
MUX McEwen Mining | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.28 -0.4% | $11.00 ➝ $12.00 | Buy ➝ Buy | |
NKTX Nkarta | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25 -0.8% | $16.00 ➝ $15.00 | Buy ➝ Buy | |
NOMD Nomad Foods | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.09 +0.9% | $26.00 ➝ $28.00 | Buy ➝ Buy | |
NOW ServiceNow | Reiterated by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $729.79 +0.9% | $830.00 | Outperform ➝ Outperform | |
NTLA Intellia Therapeutics | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.46 -1.6% | $62.00 ➝ $70.00 | Outperform ➝ Outperform | |
NTLA Intellia Therapeutics | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.46 -1.6% | $31.00 ➝ $29.00 | Neutral ➝ Neutral | |
NTR Nutrien | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.15 0.0% | $67.00 ➝ $68.00 | Overweight ➝ Overweight | |
NTRA Natera | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.29 +10.2% | $99.00 ➝ $117.00 | Outperform ➝ Outperform | |
NTRA Natera | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.29 +10.2% | $100.00 ➝ $130.00 | Buy ➝ Buy | |
NTRA Natera | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.29 +10.2% | $123.00 ➝ $137.00 | Buy ➝ Buy | |
NVAX Novavax | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.88 +98.7% | $4.00 ➝ $12.00 | Underperform ➝ Neutral | |
NVAX Novavax | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.88 +98.7% | | Underweight ➝ Neutral | |
NVDA NVIDIA | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $898.78 +1.3% | $1,050.00 ➝ $1,350.00 | Buy ➝ Buy | |
NVMI Nova | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $193.50 +0.2% | | Hold | |
NVMI Nova | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $193.50 +0.2% | $190.00 ➝ $220.00 | Buy ➝ Buy | |
NVMI Nova | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $193.50 +0.2% | $187.00 ➝ $215.00 | Buy ➝ Buy | |
NVTS Navitas Semiconductor | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.10 -12.6% | $9.00 ➝ $7.00 | Buy ➝ Buy | |
NVTS Navitas Semiconductor | Target Lowered by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.10 -12.6% | $12.00 ➝ $10.00 | Buy ➝ Buy | |
NVTS Navitas Semiconductor | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.10 -12.6% | $12.00 ➝ $7.00 | Outperform ➝ Outperform | |
NVTS Navitas Semiconductor | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.10 -12.6% | $9.00 ➝ $7.00 | Buy ➝ Buy | |
NXST Nexstar Media Group | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $172.30 -3.2% | $225.00 | Buy ➝ Buy | |
O Realty Income | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.01 +0.7% | $56.00 ➝ $59.00 | Buy ➝ Buy | |
OBDC Blue Owl Capital | Target Raised by | Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.56 +2.4% | $16.00 ➝ $17.00 | Outperform | |
ODD Oddity Tech | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.18 -2.2% | $44.00 ➝ $42.00 | Equal Weight ➝ Equal Weight | |
OKTA Okta | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.42 -0.7% | $130.00 | Outperform ➝ Outperform | |
ONTO Onto Innovation | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $224.45 +7.7% | | Hold | |
ONTO Onto Innovation | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $224.45 +7.7% | $235.00 ➝ $250.00 | Buy ➝ Buy | |
ONTO Onto Innovation | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $224.45 +7.7% | $235.00 ➝ $250.00 | Outperform ➝ Outperform | |
ONTO Onto Innovation | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $224.45 +7.7% | $180.00 ➝ $230.00 | Buy ➝ Buy | |
ORA Ormat Technologies | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.26 +1.9% | $70.00 ➝ $76.00 | Hold ➝ Hold | |
OSK Oshkosh | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $121.65 +2.1% | $158.00 ➝ $190.00 | Outperform ➝ Outperform | |
OUST Ouster | Target Raised by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.36 +19.4% | $12.00 ➝ $17.00 | Buy ➝ Buy | |
OUST Ouster | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.36 +19.4% | $10.00 ➝ $13.00 | Buy ➝ Buy | |
PACB Pacific Biosciences of California | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.77 +2.9% | $3.00 ➝ $2.00 | Equal Weight ➝ Equal Weight | |
PAHC Phibro Animal Health | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.55 -0.8% | $10.00 ➝ $13.00 | Underweight ➝ Underweight | |
PALT Paltalk | Target Lowered by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.12 -3.7% | $5.00 ➝ $4.50 | Buy ➝ Buy | |
PAR PAR Technology | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.01 +1.3% | $53.00 | Buy ➝ Buy | |
PDFS PDF Solutions | Reiterated by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.29 +4.5% | $40.00 ➝ $40.00 | Buy ➝ Buy | |
PET Wag! Group | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.39 -1.6% | $8.00 ➝ $8.00 | Buy ➝ Buy | |
PETQ PetIQ | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.44 -1.3% | $30.00 | Buy ➝ Buy | |
PGNY Progyny | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.53 -15.3% | $46.00 ➝ $37.00 | Buy ➝ Buy | |
PGNY Progyny | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.53 -15.3% | $50.00 ➝ $41.00 | Buy ➝ Buy | |
PGNY Progyny | Downgraded by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.53 -15.3% | | Overweight ➝ Sector Weight | |
PGY Pagaya Technologies | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.68 +0.6% | $22.00 | Buy ➝ Buy | |
PHAT Phathom Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.53 -5.6% | $28.00 | Buy ➝ Buy | |
PLL Piedmont Lithium | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.21 -1.4% | $20.00 ➝ $28.00 | Market Perform ➝ Market Perform | |
PLNT Planet Fitness | Downgraded by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.95 -0.6% | $80.00 ➝ $70.00 | Buy ➝ Hold | |
PLNT Planet Fitness | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.95 -0.6% | $80.00 ➝ $88.00 | Outperform ➝ Outperform | |
PLNT Planet Fitness | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.95 -0.6% | $80.00 ➝ $77.00 | Outperform ➝ Outperform | |
PLNT Planet Fitness | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.95 -0.6% | $75.00 ➝ $80.00 | Strong-Buy ➝ Strong-Buy | |
PLTK Playtika | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.58 -3.3% | $8.00 ➝ $9.00 | Neutral ➝ Neutral | |
PLTK Playtika | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.58 -3.3% | $9.00 ➝ $10.00 | Outperform ➝ Outperform | |
PLUG Plug Power | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.56 -7.6% | $3.50 ➝ $3.00 | Neutral ➝ Neutral | |
PLUG Plug Power | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.56 -7.6% | $2.90 ➝ $2.50 | Underweight ➝ Underweight | |
PLUG Plug Power | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.56 -7.6% | $3.00 ➝ $2.50 | Underweight ➝ Underweight | |
PLUG Plug Power | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.56 -7.6% | $7.00 ➝ $5.00 | Buy ➝ Buy | |
PNNT PennantPark Investment | Downgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.28 -1.5% | | Outperform ➝ Market Perform | |
PODD Insulet | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.90 -6.6% | $255.00 ➝ $260.00 | Buy ➝ Buy | |
PODD Insulet | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.90 -6.6% | $226.00 ➝ $234.00 | Buy ➝ Buy | |
PODD Insulet | Target Lowered by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.90 -6.6% | $218.00 ➝ $213.00 | Outperform ➝ Outperform | |
PRMW Primo Water | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.18 +0.9% | $17.00 ➝ $20.00 | Hold ➝ Hold | |
PRQR ProQR Therapeutics | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Nakae Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.98 -1.0% | $2.50 ➝ $2.50 | Buy ➝ Buy | |
PRQR ProQR Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.98 -1.0% | $5.00 | Buy ➝ Buy | |
PRVA Privia Health Group | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.97 -0.3% | $37.00 ➝ $26.00 | Buy ➝ Buy | |
PWSC PowerSchool | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.11 -0.1% | $29.00 ➝ $24.00 | Overweight ➝ Overweight | |
PZZA Papa John's International | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.32 +0.2% | $87.00 ➝ $75.00 | Buy ➝ Buy | |
PZZA Papa John's International | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.32 +0.2% | $77.00 ➝ $58.00 | Hold ➝ Hold | |
PZZA Papa John's International | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.32 +0.2% | $78.00 ➝ $64.00 | Overweight ➝ Overweight | |
PZZA Papa John's International | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.32 +0.2% | $80.00 ➝ $75.00 | Outperform ➝ Outperform | |
PZZA Papa John's International | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.32 +0.2% | $76.00 ➝ $65.00 | Outperform ➝ Outperform | |
PZZA Papa John's International | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.32 +0.2% | $97.00 ➝ $90.00 | Buy ➝ Buy | |
QRHC Quest Resource | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.83 -2.9% | $12.00 ➝ $15.00 | Buy ➝ Buy | |
QSI Quantum-Si | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.70 -7.1% | $4.00 | Buy ➝ Buy | |
RAPT RAPT Therapeutics | Downgraded by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.33 -7.1% | $13.00 ➝ $4.00 | Overweight ➝ Equal Weight | |
RAPT RAPT Therapeutics | Downgraded by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.33 -7.1% | | Buy ➝ Neutral | |
RBLX Roblox | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $55.00 ➝ $40.00 | Buy ➝ Buy | |
RBLX Roblox | Upgraded by | Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $31.00 ➝ $26.00 | Sell ➝ Neutral | |
RBLX Roblox | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $56.00 ➝ $46.00 | Outperform ➝ Outperform | |
RBLX Roblox | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $56.00 ➝ $40.00 | Overweight ➝ Overweight | |
RBLX Roblox | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $55.00 ➝ $40.00 | Buy ➝ Buy | |
RBLX Roblox | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $50.00 ➝ $37.00 | Overweight ➝ Overweight | |
RBLX Roblox | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $42.00 ➝ $35.00 | Equal Weight ➝ Equal Weight | |
RBLX Roblox | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $50.00 ➝ $40.00 | Buy ➝ Buy | |
RBLX Roblox | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $46.00 ➝ $35.00 | Equal Weight ➝ Equal Weight | |
RBLX Roblox | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $56.00 ➝ $48.00 | Buy ➝ Buy | |
RBLX Roblox | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.44 +3.4% | $54.00 ➝ $46.00 | Buy ➝ Buy | |
RC Ready Capital | Downgraded by | LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.37 -3.3% | | Buy ➝ Neutral | |
RDNT RadNet | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.25 +3.1% | $50.00 ➝ $60.00 | Outperform ➝ Outperform | |
RDW Redwire | Target Raised by | Longbow Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.67 +6.9% | $5.00 ➝ $6.00 | Buy ➝ Buy | |
RDW Redwire | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.67 +6.9% | $5.00 ➝ $10.00 | Buy ➝ Buy | |
RDW Redwire | Target Raised by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Sheppard Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.67 +6.9% | $5.00 ➝ $6.00 | Overweight ➝ Overweight | |
REYN Reynolds Consumer Products | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.36 +0.3% | $28.00 ➝ $29.00 | Equal Weight ➝ Equal Weight | |
RGA Reinsurance Group of America | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $208.77 +1.8% | $210.00 ➝ $227.00 | Overweight ➝ Overweight | |
RITM Rithm Capital | Reiterated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.38 +0.4% | $13.00 ➝ $14.00 | Buy ➝ Buy | |
RLAY Relay Therapeutics | Upgraded by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.42 +1.7% | $15.00 ➝ $15.00 | Equal Weight ➝ Overweight | |
RLYB Rallybio | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.83 -3.7% | $9.00 | Buy ➝ Buy | |
RNA Avidity Biosciences | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.96 -4.2% | $35.00 | Buy ➝ Buy | |
RNA Avidity Biosciences | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.96 -4.2% | $33.00 ➝ $33.00 | Buy ➝ Buy | |
RPAY Repay | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.33 -2.4% | $12.00 ➝ $13.00 | Buy ➝ Buy | |
RPAY Repay | Reiterated by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.33 -2.4% | $13.00 ➝ $13.00 | Buy ➝ Buy | |
RPD Rapid7 | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.85 -0.2% | | Hold | |
RSSS Research Solutions | Target Raised by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.91 +2.8% | $5.00 ➝ $6.00 | Buy ➝ Buy | |
RVNC Revance Therapeutics | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.32 -22.6% | $18.00 ➝ $12.00 | Buy ➝ Buy | |
RVNC Revance Therapeutics | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.32 -22.6% | $20.00 ➝ $11.00 | Overweight ➝ Overweight | |
RVNC Revance Therapeutics | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.32 -22.6% | $9.00 ➝ $8.00 | Neutral ➝ Neutral | |
RXRX Recursion Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.60 -0.5% | $17.00 | Buy ➝ Buy | |
SAFE Safehold | Downgraded by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.49 -2.2% | $22.00 ➝ $20.00 | Buy ➝ Neutral | |
SEDG SolarEdge Technologies | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.47 -6.1% | $104.00 ➝ $84.00 | Buy ➝ Buy | |
SEDG SolarEdge Technologies | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.47 -6.1% | $54.00 ➝ $44.00 | Underperform ➝ Underperform | |
SEDG SolarEdge Technologies | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.47 -6.1% | $75.00 ➝ $55.00 | Hold ➝ Hold | |
SERA Sera Prognostics | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.26 -5.4% | | Outperform | |
SG Sweetgreen | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.61 +34.2% | $22.00 ➝ $26.00 | Hold ➝ Hold | |
SG Sweetgreen | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.61 +34.2% | $20.00 ➝ $35.00 | Outperform ➝ Outperform | |
SG Sweetgreen | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.61 +34.2% | $28.00 ➝ $30.00 | Overweight ➝ Overweight | |
SG Sweetgreen | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.61 +34.2% | $16.00 ➝ $17.00 | Underweight ➝ Underweight | |
SG Sweetgreen | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.61 +34.2% | $25.00 ➝ $28.00 | Neutral ➝ Neutral | |
SGC Superior Group of Companies | Target Raised by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.03 -4.4% | $18.00 ➝ $22.00 | Outperform ➝ Outperform | |
SKIN Beauty Health | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.74 -23.7% | $3.00 ➝ $2.50 | Underweight ➝ Underweight | |
SKLZ Skillz | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.44 -15.0% | $15.00 | Outperform ➝ Outperform | |
SLNO Soleno Therapeutics | Initiated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.99 -5.6% | $72.00 | Outperform | |
SLRC SLR Investment | Reiterated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.21 +1.3% | $16.00 ➝ $17.00 | Neutral ➝ Neutral | |
SM SM Energy | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.17 -3.5% | $50.00 ➝ $54.00 | Sector Perform ➝ Sector Perform | |
SN SharkNinja | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 71.84 +0.7% | $65.00 ➝ $67.00 | Equal Weight ➝ Equal Weight | |
SN SharkNinja | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 71.84 +0.7% | $75.00 ➝ $82.00 | Buy ➝ Buy | |
SN SharkNinja | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 71.84 +0.7% | $76.00 ➝ $83.50 | Buy ➝ Buy | |
SOLV Solventum | Initiated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.74 -1.7% | $70.00 | Neutral | |
SOUN SoundHound AI | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.09 +7.2% | $9.00 | Outperform ➝ Outperform | |
SPB Spectrum Brands | Target Raised by | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.80 +0.2% | $98.00 ➝ $106.00 | Buy | |
SPB Spectrum Brands | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.80 +0.2% | $100.00 ➝ $114.00 | Outperform ➝ Outperform | |
SPB Spectrum Brands | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.80 +0.2% | $85.00 ➝ $95.00 | Equal Weight ➝ Equal Weight | |
SPB Spectrum Brands | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.80 +0.2% | $88.00 ➝ $115.00 | Outperform ➝ Outperform | |
SPB Spectrum Brands | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.80 +0.2% | $86.00 ➝ $92.00 | Hold ➝ Hold | |
SPB Spectrum Brands | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.80 +0.2% | $85.00 ➝ $91.00 | Hold ➝ Hold | |
SPSC SPS Commerce | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $192.45 -0.6% | $205.00 | Buy ➝ Buy | |
SPSC SPS Commerce | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $192.45 -0.6% | $213.00 ➝ $222.00 | Buy ➝ Buy | |
SQSP Squarespace | Upgraded by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.20 +3.7% | $34.00 ➝ $50.00 | Neutral ➝ Buy | |
SRTS Sensus Healthcare | Target Raised by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.29 +38.8% | $7.00 ➝ $10.00 | Buy ➝ Buy | |
STE STERIS | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $231.33 +2.4% | | Hold | |
STE STERIS | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $231.33 +2.4% | $220.00 ➝ $225.00 | Neutral ➝ Neutral | |
STKS ONE Group Hospitality | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.32 -3.3% | $5.00 ➝ $6.00 | Neutral ➝ Neutral | |
STNG Scorpio Tankers | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.83 +1.4% | $76.00 ➝ $82.00 | Neutral ➝ Neutral | |
SVV Savers Value Village | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.66 -20.4% | $23.00 ➝ $21.00 | Outperform ➝ Outperform | |
SVV Savers Value Village | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.66 -20.4% | $24.00 ➝ $19.00 | Overweight ➝ Overweight | |
SYM Symbotic | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.79 -6.6% | | Market Perform | |
SYNA Synaptics | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.94 -3.0% | $135.00 ➝ $115.00 | Buy ➝ Buy | |
SYNA Synaptics | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.94 -3.0% | $125.00 ➝ $110.00 | Buy ➝ Buy | |
SYNA Synaptics | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.94 -3.0% | $135.00 ➝ $115.00 | Overweight ➝ Overweight | |
SYNA Synaptics | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.94 -3.0% | $115.00 ➝ $95.00 | Equal Weight ➝ Equal Weight | |
SYRE Spyre Therapeutics | Target Raised by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.93 +4.9% | $32.00 ➝ $40.00 | Buy ➝ Buy | |
TARS Tarsus Pharmaceuticals | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.00 +8.7% | $50.00 ➝ $60.00 | Overweight ➝ Overweight | |
TDW Tidewater | Target Raised by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.76 -2.1% | $110.00 ➝ $130.00 | Buy ➝ Buy | |
TELA TELA Bio | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.77 +16.8% | $12.00 ➝ $10.00 | Overweight ➝ Overweight | |
TGLS Tecnoglass | Reiterated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.53 +1.7% | $65.00 ➝ $60.00 | Buy ➝ Buy | |
TIXT TELUS International (Cda) | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.37 +0.2% | $9.50 ➝ $7.50 | Market Perform ➝ Market Perform | |
TIXT TELUS International (Cda) | Downgraded by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.37 +0.2% | $13.00 ➝ $10.00 | Sector Outperform ➝ Sector Perform | |
TLSI TriSalus Life Sciences | Initiated by | Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.83 +0.3% | $16.00 | Buy | |
TME Tencent Music Entertainment Group | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.34 -0.3% | $13.00 ➝ $15.00 | Buy ➝ Buy | |
TNK Teekay Tankers | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.69 -0.9% | $66.00 ➝ $79.00 | Buy ➝ Buy | |
TPG TPG | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.50 -1.0% | $43.00 ➝ $52.00 | Equal Weight ➝ Overweight | |
TPL Texas Pacific Land | Reiterated by | BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $623.71 +1.4% | $917.00 ➝ $917.00 | Buy ➝ Buy | |
TPR Tapestry | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.07 -0.7% | $52.00 ➝ $50.00 | Outperform ➝ Outperform | |
TPR Tapestry | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.07 -0.7% | $56.00 ➝ $54.00 | Overweight ➝ Overweight | |
TPST Tempest Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.25 -6.3% | $47.00 | Buy ➝ Buy | |
TREX Trex | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $87.39 -6.4% | $93.00 ➝ $94.00 | Underweight ➝ Underweight | |
TREX Trex | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $87.39 -6.4% | $110.00 ➝ $105.00 | Neutral ➝ Neutral | |
TRIP Tripadvisor | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.18 -0.7% | $20.00 ➝ $15.00 | Underweight ➝ Underweight | |
TRIP Tripadvisor | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.18 -0.7% | $30.00 ➝ $21.00 | Neutral ➝ Neutral | |
TRV Travelers Companies | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $218.42 -0.5% | $214.00 ➝ $216.00 | Equal Weight ➝ Equal Weight | |
TSEM Tower Semiconductor | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.71 +0.7% | $40.00 ➝ $40.00 | Buy ➝ Buy | |
TSEM Tower Semiconductor | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.71 +0.7% | $40.00 ➝ $44.00 | Buy ➝ Buy | |
TSEM Tower Semiconductor | Upgraded by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.71 +0.7% | $36.00 ➝ $55.00 | Neutral ➝ Positive | |
TTEC TTEC | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.27 +1.7% | $18.00 ➝ $13.00 | Buy ➝ Buy | |
TTEC TTEC | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.27 +1.7% | $13.00 ➝ $8.00 | Hold ➝ Hold | |
TTGT TechTarget | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.19 +4.8% | $41.00 ➝ $34.00 | Hold ➝ Hold | |
TTGT TechTarget | Target Lowered by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.19 +4.8% | $45.00 ➝ $39.00 | Outperform ➝ Outperform | |
TTGT TechTarget | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.19 +4.8% | $40.00 ➝ $33.00 | Hold ➝ Hold | |
TTGT TechTarget | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.19 +4.8% | $50.00 | Buy ➝ Buy | |
TYRA Tyra Biosciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.35 -2.3% | $23.00 | Buy ➝ Buy | |
TYRA Tyra Biosciences | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.35 -2.3% | $28.00 | Outperform ➝ Outperform | |
U Unity Software | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68 -10.3% | | Market Perform | |
U Unity Software | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68 -10.3% | $16.00 | Sell ➝ Sell | |
U Unity Software | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68 -10.3% | $28.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
U Unity Software | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68 -10.3% | $31.00 | Buy ➝ Buy | |
U Unity Software | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68 -10.3% | $33.50 | Outperform ➝ Outperform | |
UAA Under Armour | Target Lowered by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.71 -1.2% | $9.00 ➝ $8.00 | Market Perform ➝ Market Perform | |
UBER Uber Technologies | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.97 -1.4% | $91.00 ➝ $89.00 | Buy ➝ Buy | |
USFD US Foods | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.81 +0.0% | $58.00 ➝ $62.00 | Outperform ➝ Outperform | |
USFD US Foods | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.81 +0.0% | $60.00 ➝ $64.00 | Overweight ➝ Overweight | |
USFD US Foods | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.81 +0.0% | $64.00 ➝ $67.00 | Buy ➝ Buy | |
USFD US Foods | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.81 +0.0% | $57.00 ➝ $65.00 | Buy ➝ Buy | |
USFD US Foods | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.81 +0.0% | $62.00 ➝ $64.00 | Overweight ➝ Overweight | |
UWMC UWM | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.11 -5.3% | $6.00 ➝ $7.00 | Market Perform ➝ Market Perform | |
UWMC UWM | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.11 -5.3% | $7.00 | Neutral ➝ Neutral | |
VAL Valaris | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.90 -2.3% | $102.00 ➝ $98.00 | Overweight ➝ Overweight | |
VC Visteon | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $114.44 -0.9% | $145.00 ➝ $135.00 | Equal Weight ➝ Equal Weight | |
VCSA Vacasa | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.99 -8.0% | $10.00 ➝ $8.00 | Buy ➝ Buy | |
VERA Vera Therapeutics | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.32 -2.4% | $57.00 ➝ $68.00 | Strong-Buy ➝ Strong-Buy | |
VICI VICI Properties | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.49 +0.6% | $31.00 ➝ $32.00 | Buy ➝ Buy | |
VITL Vital Farms | Downgraded by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.41 -4.1% | $30.00 ➝ $40.00 | Buy ➝ Hold | |
VITL Vital Farms | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.41 -4.1% | $19.00 ➝ $37.00 | Hold ➝ Hold | |
VOR Vor Biopharma | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.71 -5.5% | $11.00 | Outperform ➝ Outperform | |
VOYA Voya Financial | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.46
| $91.00 ➝ $92.00 | Overweight ➝ Overweight | |
VSCO Victoria's Secret & Co. | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.60 +5.4% | $20.00 ➝ $20.00 | Market Perform ➝ Market Perform | |
VSEC VSE | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $79.78 -1.1% | $91.00 ➝ $101.00 | Buy ➝ Buy | |
VSEC VSE | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $79.78 -1.1% | $86.00 ➝ $92.00 | Buy ➝ Buy | |
VST Vistra | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $93.49 +0.3% | $79.00 ➝ $109.00 | Outperform ➝ Outperform | |
VSTO Vista Outdoor | Target Raised by | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.59 -1.5% | $37.00 ➝ $41.00 | Buy | |
VSTO Vista Outdoor | Downgraded by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.59 -1.5% | $33.00 ➝ $37.00 | Buy ➝ Hold | |
VYX NCR Voyix | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.47 +2.5% | $20.00 | Buy | |
WBD Warner Bros. Discovery | Target Lowered by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.15 +1.4% | $11.00 ➝ $10.00 | Outperform ➝ Outperform | |
WBD Warner Bros. Discovery | Upgraded by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.15 +1.4% | $11.00 | Sector Weight ➝ Overweight | |
WBD Warner Bros. Discovery | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.15 +1.4% | | Hold | |
WBX Wallbox | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.42 -5.3% | $5.00 ➝ $4.00 | Buy ➝ Buy | |
WMB Williams Companies | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.64 +0.2% | $37.00 ➝ $38.00 | Equal Weight ➝ Equal Weight | |
WMT Walmart | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.48 +0.1% | $68.00 ➝ $68.00 | Outperform ➝ Outperform | |
WPRT Westport Fuel Systems | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.81 +3.8% | $30.00 ➝ $22.00 | Buy ➝ Buy | |
WRBY Warby Parker | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.79 +0.7% | $13.00 ➝ $15.00 | Neutral ➝ Neutral | |
WRBY Warby Parker | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.79 +0.7% | $13.00 ➝ $14.00 | Equal Weight ➝ Equal Weight | |
WTS Watts Water Technologies | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $212.88 +0.8% | $212.00 ➝ $225.00 | Neutral ➝ Neutral | |
XENE Xenon Pharmaceuticals | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.54 -4.6% | $51.00 ➝ $50.00 | Outperform ➝ Outperform | |
XENE Xenon Pharmaceuticals | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.54 -4.6% | $62.00 ➝ $60.00 | Buy ➝ Buy | |
XENE Xenon Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.54 -4.6% | $62.00 ➝ $62.00 | Buy ➝ Buy | |
XERS Xeris Biopharma | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.76 -6.4% | $4.00 ➝ $3.00 | Overweight ➝ Overweight | |
XMTR Xometry | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.30 +3.5% | $23.00 ➝ $20.00 | Buy ➝ Buy | |
XNCR Xencor | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.48 -4.5% | $34.00 ➝ $36.00 | Outperform ➝ Outperform | |
YELP Yelp | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.79 -7.1% | $44.00 ➝ $39.00 | Neutral ➝ Neutral | |
YELP Yelp | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.79 -7.1% | $55.00 ➝ $48.00 | Buy ➝ Buy | |
YETI YETI | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.65 +1.0% | $39.00 ➝ $41.00 | Equal Weight ➝ Equal Weight | |
YETI YETI | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.65 +1.0% | $48.00 ➝ $49.00 | Outperform ➝ Outperform | |
YETI YETI | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.65 +1.0% | $40.00 ➝ $42.00 | Hold ➝ Hold | |
YETI YETI | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.65 +1.0% | $43.00 ➝ $42.00 | Neutral ➝ Neutral | |
YETI YETI | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.65 +1.0% | $38.00 ➝ $43.00 | Hold ➝ Hold | |
YETI YETI | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.65 +1.0% | $52.00 ➝ $54.00 | Overweight ➝ Overweight | |
ZD Ziff Davis | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.17 -3.6% | $68.00 ➝ $58.00 | Equal Weight ➝ Equal Weight | |
ZD Ziff Davis | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.17 -3.6% | $78.00 ➝ $70.00 | Outperform ➝ Outperform | |
ZD Ziff Davis | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.17 -3.6% | $74.00 ➝ $62.00 | Neutral ➝ Neutral | |
ZURA Zura Bio | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.68 +1.7% | $16.00 ➝ $21.00 | Outperform ➝ Outperform | |